Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 60Prostatic Neoplasms 52Squamous Cell Carcinoma of Head and Neck 43Carcinoma, Non-Small-Cell Lung 39Head and Neck Neoplasms 37Lung Neoplasms 35Lymphoma 34Leukemia 22Brain Neoplasms 20Central Nervous System Neoplasms 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Glioblastoma 18Uterine Cervical Neoplasms 17Sarcoma 17Rectal Neoplasms 17Lymphoma, Follicular 16Esophageal Squamous Cell Carcinoma 16Esophageal Neoplasms 15Lymphoma, Large B-Cell, Diffuse 14Hodgkin Disease 14Burkitt Lymphoma 14Adenocarcinoma of Lung 13Oligodendroglioma 12Lymphoma, Non-Hodgkin 12Neoplasm Metastasis 11Astrocytoma 11Rhabdomyosarcoma 10Lymphoma, Large-Cell, Immunoblastic 10Neuroblastoma 9Nasopharyngeal Carcinoma 9

Interventions

tislelizumab 1motexafin gadolinium 1Tamoxifen 1Talaporfin 1Radiotherapy 1Oxaliplatin 1Mitomycin 1Lomustine 1Irinotecan 1Gemcitabine 1Folfox protocol 1Fluorouracil 1Ethiodized Oil 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Neoplasm Recurrence, Local × Radiotherapy × Clear all
NCT00138814 2005-12-15

Boost Use in Breast Conservation Radiotherapy

St George Hospital, Australia

Phase 3 Unknown
680 enrolled
Breast

Breast Neoplasms, Neoplasm Recurrence, Local

Data powered by HemOnc (CC BY 4.0) Colophon âš¡